Evidence map›Paper›PMID 40837403›Full record

ArticleFrontiers in bioinformatics2025

In silico analysis of CSF2RB from cancer genomic databases reveals a heterogeneous role in different breast cancer subtypes.

Raghad Alshelaiel, Abdulmohsen Alkushi, Lolwah Abdullah Alriyees, Abir Abdullah Alamro, Humidah Alanazi, Areej Alhareeri, Bader AlMuzzaini, Mamoon Rashid

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Raghad AlshelaielDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Abdulmohsen AlkushiCollege of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Lolwah Abdullah AlriyeesKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abir Abdullah AlamroDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Humidah AlanaziDepartment of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
Areej AlhareeriKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Bader AlMuzzainiDepartment of Medical Genomics, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Mamoon RashidKing Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: We analyzed Results: Our Conclusion: The results suggest a diverse role for the

Indexed as

bioinformaticsbreast cancercancercancer genomicscolony-stimulating factor 2 receptor subunit betaprognosis

Identifiers

PMID40837403
PMCPMC12361248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.